- Home
- LITB vs CLRB Comparison
LITB vs CLRB Comparison
Compare LITB & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- CLRB
- Stock Information
- Founded
- LITB 2007
- CLRB 2002
- Country
- LITB Singapore
- CLRB United States
- Employees
- LITB N/A
- CLRB N/A
- Industry
- LITB Catalog/Specialty Distribution
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- CLRB Health Care
- Exchange
- LITB Nasdaq
- CLRB Nasdaq
- Market Cap
- LITB 21.1M
- CLRB 17.6M
- IPO Year
- LITB N/A
- CLRB N/A
- Fundamental
- Price
- LITB $1.31
- CLRB $4.88
- Analyst Decision
- LITB
- CLRB Hold
- Analyst Count
- LITB 0
- CLRB 2
- Target Price
- LITB N/A
- CLRB N/A
- AVG Volume (30 Days)
- LITB 10.8K
- CLRB 198.9K
- Earning Date
- LITB 08-01-2025
- CLRB 08-12-2025
- Dividend Yield
- LITB N/A
- CLRB N/A
- EPS Growth
- LITB N/A
- CLRB N/A
- EPS
- LITB 0.08
- CLRB N/A
- Revenue
- LITB $231,136,000.00
- CLRB N/A
- Revenue This Year
- LITB N/A
- CLRB N/A
- Revenue Next Year
- LITB N/A
- CLRB N/A
- P/E Ratio
- LITB $16.67
- CLRB N/A
- Revenue Growth
- LITB N/A
- CLRB N/A
- 52 Week Low
- LITB $0.91
- CLRB $4.36
- 52 Week High
- LITB $4.98
- CLRB $94.50
- Technical
- Relative Strength Index (RSI)
- LITB 57.98
- CLRB 34.07
- Support Level
- LITB $1.22
- CLRB $4.62
- Resistance Level
- LITB $1.34
- CLRB $5.05
- Average True Range (ATR)
- LITB 0.08
- CLRB 0.88
- MACD
- LITB 0.02
- CLRB -0.35
- Stochastic Oscillator
- LITB 82.76
- CLRB 8.92
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.